Integra Lifesciences Holdings Corporation · NASDAQ:IART

Integra Lifesciences — Q1 2009 Earnings Presentation

15 slides from Integra Lifesciences's earnings presentation, May 6, 2009

  1. Slide 1: Quarterly Financial Summary May 2009

    Quarterly Financial Summary May 2009 A world leader in regenerative medicine and medical devices used in neurosurgery, extremities reconstruction, orthopedics and general surgery

  2. Slide 2: Statements of Operations (2007 - 2009)

    STATEMENTS OF OPERATIONS (2007 - 2009) (in thousands) *Adjusted to reflect the implementation of FSP APB 14-1

  3. Slide 3: Statements of Operations (Q1 07 - Q4 07)

    STATEMENTS OF OPERATIONS (Q1 07 - Q4 07) (in thousands) *Adjusted to reflect the implementation of FSP APB 14-1

  4. Slide 4: Statements of Operations (Q1 08 - Q4 08)

    STATEMENTS OF OPERATIONS (Q1 08 - Q4 08) (in thousands) *Adjusted to reflect the implementation of FSP APB 14-1

  5. Slide 5: Statements of Operations (Q1 09)

    STATEMENTS OF OPERATIONS (Q1 09) (in thousands, except per share data)

  6. Slide 6: Balance Sheet, Cash Flows and Capital Structure

    Balance Sheet, Cash Flows and Capital Structure* *Adjusted to reflect the implementation of FSP APB 14-1

  7. Slide 7: Quarterly Adjusted EBITDA and Adjusted Earnings per Diluted Share

    QUARTERLY ADJUSTED EBITDA, ADJUSTED EBITDA EXCLUDING SHARE-BASED COMPENSATION, AND ADJUSTED EARNINGS PER DILUTED SHARE In addition to our GAAP results, we provide adjusted EBITDA, adjusted EBITDA excluding stock-based compensation, adjusted net income and adjusted earnings per diluted share. Adjuste

  8. Slide 8: Adjusted EBITDA (Q1 07 - Q1 09)

    A reconciliation of reported GAAP Net Income to Adjusted EBITDA is provided at the end of this presentation ADJUSTED EBITDA (Q1 07 - Q1 09) (in thousands) *Adjusted to reflect the implementation of FSP APB 14-1

  9. Slide 9: Adjusted EBITDA Excluding Stock-Based Compensation (Q1 07 - Q1 09)

    A reconciliation of reported GAAP Net Income to Adjusted EBITDA excluding stock-based compensation is provided at the end of this presentation ADJUSTED EBITDA EXCLUDING STOCK- BASED COMPENSATION (Q1 07 - Q1 09) (in thousands) *Adjusted to reflect the implementation of FSP APB 14-1

  10. Slide 10: Net Income to Adjusted EBITDA (Q1 07 - Q4 07)

    RECONCILIATION OF REPORTED GAAP NET INCOME TO ADJUSTED EBITDA AND ADJUSTED EBITDA EXCLUDING STOCK-BASED COMPENSATION (Q1 07 - Q4 07) *Adjusted to reflect the implementation of FSP APB 14-1

  11. Slide 11: Net Income to Adjusted EBITDA (Q1 08 - Q4 08)

    RECONCILIATION OF REPORTED GAAP NET INCOME TO ADJUSTED EBITDA AND ADJUSTED EBITDA EXCLUDING STOCK-BASED COMPENSATION (Q1 08 - Q4 08) *Adjusted to reflect the implementation of FSP APB 14-1

  12. Slide 12: Net Income to Adjusted EBITDA (Q1 09)

    RECONCILIATION OF REPORTED GAAP NET INCOME TO ADJUSTED EBITDA AND ADJUSTED EBITDA EXCLUDING STOCK-BASED COMPENSATION (Q1 09)

  13. Slide 13: Net Income to Adjusted Net Income (Q1 - Q4 07)

    RECONCILIATION OF REPORTED GAAP NET INCOME TO ADJUSTED NET INCOME (Q1 07 - Q4 07) *Adjusted to reflect the implementation of FSP APB 14-1

  14. Slide 14: Net Income to Adjusted Net Income (Q1 - Q4 08)

    RECONCILIATION OF REPORTED GAAP NET INCOME TO ADJUSTED NET INCOME (Q1 08 - Q4 08) *Adjusted to reflect the implementation of FSP APB 14-1

  15. Slide 15: Earnings per Diluted Share to Adjusted Earnings per Diluted Share (Q1 09)

    RECONCILIATION OF REPORTED GAAP EARNINGS PER DILUTED SHARE TO ADJUSTED EARNINGS PER DILUTED SHARE (Q1 09)

Integra LifeSciences Holdings — Q1 2009 Earnings Presentation on 6ix